Collectively, results from the KANON trial and CBP suggest there may be a spectrum of ACL healing, whereby a more ‘normal’ MRI appearance of the ACL may be associated with favourable patient outcomes.

Perhaps it is time we redefine what a ‘normal’ MRI is and start being ‘CLEAR’ with patients when discussing imaging results—consistent language, including epidemiological information and assessment of ...